I recommend waiting for a better discount before investing in Apexigen Inc. (APGN).

After finishing at $1.93 in the prior trading day, Apexigen Inc. (NASDAQ: APGN) closed at $2.00, up 3.63%. In other words, the price has increased by $+0.0700 from its previous closing price. On the day, 589227 shares were traded. APGN stock price reached its highest trading level at $2.0500 during the session, while it also had its lowest trading level at $1.8000.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…



Our goal is to gain a better understanding of APGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Stock Price History:

Over the past 52 weeks, APGN has reached a high of $31.35, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 1.5092, while the 200-Day Moving Average is calculated to be 6.3564.

Shares Statistics:

The stock has traded on average 1.92M shares per day over the past 3-months and 11.77M shares per day over the last 10 days, according to various share statistics. A total of 22.57M shares are outstanding, with a floating share count of 20.74M. Insiders hold about 2.90% of the company’s shares, while institutions hold 28.10% stake in the company. Shares short for APGN as of Oct 13, 2022 were 42.06k with a Short Ratio of 0.02M, compared to 39.88k on Sep 14, 2022.

Earnings Estimates

Its stock is currently analyzed by 1 different market analysts. The consensus estimate for the next quarter is -$0.4, with high estimates of -$0.4 and low estimates of -$0.4.

Analysts are recommending an EPS of between -$1.78 and -$1.78 for the fiscal current year, implying an average EPS of -$1.78. EPS for the following year is -$1.29, with 1 analysts recommending between -$1.29 and -$1.29.